BDBM616890 US11752149, Example 2

SMILES COc1cccc(c1)S(=O)(=O)CCC(=O)N1CC2CCC(C1)N2c1ccc(cn1)C#N

InChI Key

Data  4 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 616890   

TargetMuscarinic acetylcholine receptor M1(Human)
Pipeline Therapeutics

US Patent
LigandPNGBDBM616890(US11752149, Example 2)
Affinity DataIC50: 55nMAssay Description:Primary compound plates were prepared in 100% DMSO in opaque 96-well plates (VWR) and serially diluted in half log increments. Secondary compound pla...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2023
Entry Details
Go to US Patent

TargetMuscarinic acetylcholine receptor M2(Human)
Pipeline Therapeutics

US Patent
LigandPNGBDBM616890(US11752149, Example 2)
Affinity DataIC50: 1.00E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2023
Entry Details
Go to US Patent

TargetMuscarinic acetylcholine receptor M3(Human)
Pipeline Therapeutics

US Patent
LigandPNGBDBM616890(US11752149, Example 2)
Affinity DataIC50: 550nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2023
Entry Details
Go to US Patent

TargetMuscarinic acetylcholine receptor M4(Human)
Pipeline Therapeutics

US Patent
LigandPNGBDBM616890(US11752149, Example 2)
Affinity DataIC50: 550nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2023
Entry Details
Go to US Patent